An epitope present in the 71-90 sequence of basic protein (BP) has been identified as the dominant epitope recognized by most Lewis rat encephalitogenic T cells isolated during experimental autoimmune encephalomyelitis (EAE). In the present study, we investigated the BP epitopes recognized by Lewis rat T cells in naive rats, in rats suffering from acute EAE, and in recovered rats. T cells isolated from the spinal cord lesions and from the lymph nodes were studied using T cell lines and bulk cultures. Virulence of the T cells was assayed by adoptive transfer. We now report that naive and recovered Lewis rats are populated with T cells reactive to a variety of BP epitopes and only a minority are specific for the 71-90 epitope. In contrast, the induction of EAE was associated with a predominance ofT cells reactive to the 71-90 epitope. T cells recovered from naive, diseased, or recovered rats were found to be virulent upon passive transfer. Some of these virulent T cells were specific to BP epitopes other than the 71-90 epitope. There was no major difference in the BP specificities of T cells isolated from the lesions and from the lymph nodes. Thus, natural T cell reactivity to BP is heterogeneous and pathogenicity is not confined to one particular epitope, active disease is characterized by a dominant response to the 71-90 epitope, and recovery is marked by a return to heterogeneity. (J. Clin. Invest. 1993. 92:2199-2206
Introduction
Experimental autoimmune encephalomyelitis (EAE)' is an inflammatory disease of the central nervous system inducible in susceptible strains of rats and mice by active immunization with neuroantigens in adjuvant ( 1 ) or by the adoptive transfer of encephalitogenic T cell lines or clones (2) . The introduction of T cell lines and clones to the study of EAE has made it possible to analyze the epitope specificity ofencephalitogenic T cells. Virulent T cells obtained from Lewis rats developing ac-tive EAE were found to recognize primarily an epitope in the 71-90 portion of the guinea pig and rat basic protein (BP) sequences ( 1, 3) . However, potentially virulent anti-BP T cells have also been isolated from naive Lewis rats (4, 5) and from rats recovered from acute EAE and resistant to reinduction of disease (6, 7) . The presence of such T cells in animals free of disease may be viewed as a form ofbenign autoimmunity. The development of EAE, therefore, involves a transition from benign to pernicious autoimmunity and, in the case of recovery, back again to benign autoimmunity (8) .
To begin to understand the evolution ofanti-BP autoimmunity, we need to have more information about the BP specificities of the T cells present before, during, and after the disease. Are there shifts in repertoire as disease evolves? Moreover, are there differences in the BP epitopes recognized by T cells in the spinal cord lesions and by T cells in the lymph nodes? We investigated these questions by raising T cell lines from limiting numbers of cells as well as by studying the responses of lymphocytes in bulk cultures. The isolated lines made it possible to detect anti-BP specificities that otherwise might have been obscured by regulatory mechanisms or by overgrowth of dominant clones in bulk culture.
We found that the natural T cell repertoire to BP was heterogeneous in disease-free rats, but the response became dominated by the 71-90 epitope in the acute phase of EAE. There was no difference between the BP specificities of T cells obtained from the spinal cord and the lymph nodes. Thus, the onset of EAE is marked by a contraction of the T cell response to a single dominant epitope, whereas benign autoimmunity both before and after disease is characterized by epitope heterogeneity. Methods
Rats. Inbred Lewis rats were supplied monthly by Harlan Olac (Bicester, UK) and were used at 2-3 mo of age. Rats were matched for age and sex in each experiment.
Antigens. BP from the spinal cords of guinea pigs or rats was prepared as described (9 Preparation ofcell suspensions. Rats were killed by ether anesthesia, and cell suspensions were prepared from lymph nodes and thymuses by pressing the organs through a fine wire mesh (9) . Spinal cords were extruded from the vertebral column aseptically by passing a wooden applicator through the spinal canal ( 1 1). Spinal cord lymphocytes were obtained by gentle grinding ofspinal cord tissue with a 15-ml tissue grinder (Dounce model 357544; Kontes Glass Co., Wheaton, NJ) in 10 ml of PBS. The homogenate was then subjected to two to three cycles of Ficoll gradient separation. The nervous tissue remained at the interface and the lymphocytes were recovered from the pellet.
T cell lines from lymph nodes. Antigen-specific T cell lines were established from lymph node cells that had been stimulated with Con A (1.2 gg/ml) for 2 or 3 d in stimulation medium composed of DME supplemented with 2-mercaptoethanol (5 X 10-5 M), L-glutamine (2 mM), sodium pyruvate ( 1 mM), penicillin ( 100 U/ml), streptomycin (100 gg/ml), nonessential amino acids ( 1 ml/ 100 ml; Bio Lab, Jerusalem, Israel), and autologous serum 1% (vol/vol) ( 12 Packard Instrument Co.). The proliferations ofthe spinal cord-derived T cell lines were harvested using liquid scintillation vials and read with a liquid scintillation counter (GAMMAmatic B; Kontron Instruments, Zurich, Switzerland). This form of harvesting usually yielded background readings (line with thymocytes without antigen) that were 20-fold higher than the Matrix 96 direct beta counter (average 3,000 cpm, compared with 150 cpm).
Adoptive transfer ofEAE. Anti-BP T cell lines were injected intraperitoneally in the numbers indicated to groups of four rats (2, 9). The rats were observed daily for the clinical signs of EAE. Line-mediated EAE appeared 4-6 d after injection and lasted for 3-5 d.
Flow cytometry. Line cells were stained at 40C for 45 min with the following monoclonal antibodies at a 1 :100 dilution: w3/25 for CD4, MRC ox-8 for CD8, and R7.3 for af3 TCR. All antibodies were purchased from Serotec, (Oxford, England). Secondary rabbit anti-mouse FITC-conjugated antibodies were used at a 1:50 dilution at 40C for 30 min. The cells were then washed and fluorescence was measured using the FACScanO (Becton Dickinson & Co., Mountain View, CA).
Results
Naive animals: heterogeneity in the response of T cell lines to BP. The immune response to BP in the naive rat has not been studied previously in detail. Schluesener and Wekerle (5) reported that it was possible to isolate encephalitogenic T cell lines from unprimed Lewis rats. These lines reacted to an epitope in the 68-88 region of BP, equivalent to the 71-90 peptide. To increase the chances of isolating T cells reactive to other epitopes in addition to the dominant epitope in the 71-90 sequence of BP, we seeded each well with only 500 T cells from bulk cultures ofT cell blasts that had been first stimulated with the T cell mitogen Con A. 17 lines were raised from this low initial number of blasts. Therefore, we can estimate the approximate frequency of BP-responsive T cell blasts in the naive animal to be 1 in 2,800 (17 of 96 wells divided by 500 cells seeded per well). Table I 12 ofEAE induction; these lines were described in part in a previous study ( 11) . A second experiment (not shown) was done using donor rats on day 11 after induction of Fig. 1 show (Fig. 3) , although we were able to isolate virulent anti-BP lines from naive rats (Table I) . Thus, it appears to be easier to isolate anti-BP T cells from naive rats using limiting numbers ofcells than it is to detect the presence ofthe T cells in bulk cultures. In contrast tothe lymph node cells from the naive animals, lymph node cells obtained on day 11 of EAE induction revealed a response to the classical encephalitogenic 71-90 epitope as well as to guinea pig BP and rat BP. On day 16 of EAE induction (Fig. 4) , the cells responded to four peptides, including 35-52, 50-69, 68-86, and 88-101. The responses to BP epitopes were more marked after the Con A enrichment protocol ( 12) . A similar pattern of response was observed on day 140 of EAE induction, 4 mo after recovery. Thus, recovery from EAE was associated with a return to T cell heterogeneity to BP.
Discussion
Most studies of the anti-BP response profile of Lewis rats have used a similar technique to generate pathogenic T cell lines: the repeated stimulation in bulk culture of popliteal lymph node cells draining the site of BP/CFA injection on day 10 of EAE induction ( 1, 2, 3, 9, 13) . The results ofthose studies indicated that the anti-BP T cell repertoire is dominated by cells responding to the 71-90 peptide. This study was designed to facilitate the detection of heterogeneity in the response to BP and involved the generation of 54 T cell lines and 22 T cell clones from unprimed rats, from rats with acute EAE, and from rats after recovery. Schluesener and Wekerle (5) isolated from naive rats pathogenic anti-BP T cells specific for the 68-88 (71-90) segment of BP. Our findings indicate that the anti-BP T cells present in naive, healthy rats are directed to a variety of epitopes of the BP molecule; only about one-quarter of the T cells were specific to the 71-90 peptide. However, these 71-90 lines were virulent and could cause EAE in naive recipients (Table II) . The anti-BP T cells responsive to other epitopes tended not to be pathogenic. Thus, the immune system's natural picture of BP, the immunological homunculus (14, 15) , includes both virulent and avirulent T cells.
The fact that anti-BP T cells were detectable as isolated lines but not in bulk culture (Fig. 3) suggests that the lymphoid populations might contain regulatory cells that can suppress T cell lines isolated from the spinal cord infiltrates on day 12 of EAE induction were analyzed in a proliferation assay against MBP peptides and whole guinea pig BP (GpBP). These proliferations were harvested using liquid scintillation vials and read with a liquid scintillation counter (Kontron).
the response ofthe anti-BP T cells ( 16) . Apparently, the regulatory cells are lost in the process of raising lines. Note, however, that lines isolated from naive rats could produce EAE upon inoculation into other naive rats; thus, the putative regulatory cells present in naive rats are of limited effectiveness and can be overcome by administration of a sufficient number ofactivated anti-BP T cells. Alternatively, it is possible that the anti-BP T cells in naive rats do not grow in bulk culture and do not cause EAE because they exist in too low a frequency. This naturally low frequency of anti-BP T cells in naive rats could have precluded their detection in a proliferation assay, whereas the derivation of T cell lines was not affected. ( 18) .
In addition to anti-BP suppressor T cells ( 19) , antiidiotypic T cells (20, 21 ) might also might be invoked to explain how anti-BP T cells can exist in naive rats without causing disease; but such mechanisms do not explain why the 71-90 T cells ( 14, 15, 24 Recovery from EAE has been found to be accompanied by antiidiotypic T cells specific to the virulent anti-BP T cells (6, 20) . The amplification of antiidiotypic regulation by the disease itself may account for the resistance to repeated EAE asso- This work provides a basis for interpreting the anti-BP repertoires found in patients with multiple sclerosis and in normal individuals. A diversity ofepitopes were found to be recognized by T cells from healthy humans but fewer epitopes were recognized by T cells of patients with multiple sclerosis (28) . It is conceivable that the more restricted repertoire seen in multiple sclerosis patients is the result of epitope domination of the autoimmune response during disease, in analogy to the situation we see in Lewis rats with acute EAE. Hence the time of sampling of T cells from patients with multiple sclerosis may influence the results of an analysis of the repertoire. T cell lines generated from a patient during an acute attack may show immunodominance of one or a few epitopes, whereas lines generated during a remission may reveal a diverse pattern of peptide recognition. 
